Recovery

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the topical treatment of affected areas in adults and children aged 12 years and older.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the medication is not to exceed 3 to 4 times daily. It is important to note that this medication is not recommended for use in children under 12 years of age.

Healthcare professionals should ensure that the dosing frequency adheres to the specified limits to avoid potential adverse effects. Proper assessment of the patient's age and condition is essential prior to administration.

Contraindications

The product is contraindicated for use on wounds or damaged skin due to the potential for irritation or adverse reactions. Additionally, it should not be used in conjunction with other medications, herbs, or supplements unless under the supervision of a healthcare professional, as this may lead to unforeseen interactions or complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

It is imperative that this product not be applied to wounds or damaged skin. Additionally, individuals should refrain from using this product concurrently with other medications, herbs, or supplements unless under the supervision of a healthcare professional to avoid potential interactions.

In the event that the condition worsens, or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, the user should discontinue use and consult a doctor for further evaluation.

If the product is ingested, immediate medical assistance should be sought, or the user should contact a Poison Control Center without delay to ensure appropriate care is provided.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from fire or flame.

In clinical practice, it is advised that patients discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. These precautions are important to ensure patient safety and effective management of their condition.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Recovery (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age are not recommended to use this product. For adolescents aged 12 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Healthcare professionals should advise caregivers to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this product. The potential risks associated with the use of this product during pregnancy or lactation have not been established, and it is advised to avoid exposure to ensure the safety of both the mother and the fetus. Healthcare professionals should counsel women of childbearing potential regarding the importance of effective contraception during treatment and the need to discontinue use if pregnancy occurs.

Lactation

Lactating mothers are advised against the use of this product while breastfeeding. There is no available data on the excretion of the product in human milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution and consider the overall clinical context when prescribing this medication to patients with hepatic impairment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Monitoring of vital signs and laboratory parameters may be warranted to assess the patient's condition and guide further management.

Healthcare professionals should also consider contacting a poison control center or a medical toxicologist for additional guidance on the management of potential overdosage scenarios.

Nonclinical Toxicology

The available nonclinical data indicate significant concerns regarding the use of this product. Both teratogenic and non-teratogenic effects have been identified, leading to a strong recommendation against its use.

No relevant information is provided regarding carcinogenesis, mutagenesis, or impairment of fertility. Additionally, there is no pertinent data available in the context of animal pharmacology and toxicology.

Postmarketing Experience

No specific postmarketing experience details are available in the provided text. As such, there are no reported adverse events or case reports to summarize.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin to prevent further complications.

Patients should be cautioned against using the product concurrently with other medications, herbs, or supplements unless they have consulted with their healthcare provider. Providers should emphasize the importance of monitoring their condition and to discontinue use and consult a doctor if symptoms worsen, persist for more than 7 days, or if symptoms resolve and then recur within a few days.

Additionally, healthcare providers should remind patients to avoid contact with the eyes while using the product. They should also advise against tightly bandaging the area where the product is applied to ensure proper usage and minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light, and must not be frozen. Once opened, the product should be discarded after use to ensure safety and efficacy.

It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay. Users should not utilize the product if the security seal around the tin is broken or missing.

Additionally, the company supports recycling initiatives and encourages users to recycle the packaging where possible.

Additional Clinical Information

Patients should be informed that the product is administered via a topical route. Clinicians are advised to emphasize the importance of reading all product information prior to use and to retain the packaging for complete details. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Recovery, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)